Cytokine gene therapy for myocarditis by in vivo electroporation

Human Gene Therapy

Volumn 12, Issue 10, 2001, Pages 1289-1297

  Nakano, A ^a,b   Matsumori, A ^a   Kawamoto, S ^b   Tahara, H ^c   Yamato, E ^b   Sasayama, S ^a   Miyazaki, J I ^b  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10 RECEPTOR; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; ELECTROPORATION; ENCEPHALOMYOCARDITIS VIRUS; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HISTOPATHOLOGY; IN VIVO STUDY; INOCULATION; MALE; MOUSE; NONHUMAN; PLASMID; SURVIVAL RATE; TREATMENT OUTCOME; VIRUS MYOCARDITIS;

ANIMALS; BLOTTING, WESTERN; CYTOKINES; DNA, COMPLEMENTARY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ELECTROPORATION; ENCEPHALOMYOCARDITIS VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; INTERLEUKIN-10; MALE; MICE; MICE, INBRED DBA; MUSCLES; MYOCARDITIS; MYOCARDIUM; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PLASMIDS; RATS; RECEPTORS, INTERLEUKIN-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

ALPHAVIRUS; ANIMALIA; ENCEPHALOMYOCARDITIS VIRUS;

EID: 0034923657     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303401750270940     Document Type: Article

References (31)

1. Gene transfer into muscle by electroporation in vivo
2. Interleukin-1 receptor antagonist: Role in biology
3. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium
4. Alternation in cardiac gene expression during the transition from stable hypertrophy to heart failure: Marked upregulation of genes encoding extracellular matrix components
5. Molecular aspects of myocarditis
6. Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation
7. Balance of IL-1 receptor antagonist/IL-1β in rheumatoid synovium and its regulation by IL-4 and IL-10
8. Lipid-mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responses
9. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down regulation of class II major histocompatibility complex expression
10. Interleukin-1β modulates myocardial contraction via dexamethasone-sensitive production of nitric oxide
11. Recombinant IL-1 receptor antagonist protects against TNF-induced lethality in mice
12. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
13. Production of interleukin-1-receptor antagonist during experimental endotoxaemia
14. Expression of IL-10 activity by Epstein-Barr virus protein BCRF1
15. Coxsackievirus B-3 myocarditis in BALB/c mice: Evidence for autoimmunity to myocyte antigens
16. Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats
17. Molecular and immune mechanisms in the pathogenesis of cardiomyopathy: Role of viruses, cytokines, and nitric oxide
18. Low-dose N-nitro-l-arginine methyl ester treatment improves survival rate and decreases myocardial injury in a murine model of viral myocarditis induced by coxsackievirus B3
19. Treatment of experimental viral myocarditis with interleukin-10
20. Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice
21. Efficient selection for high-expression transfectants with a novel eukaryotic vector
22. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR
23. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor β
24. Restricted usage of T cell receptor Va-Vb genes in infiltrating cells in the hearts of patients with acute myocarditis and dilated cardiomyopathy
25. Persistent expression of cytokine in the chronic stage of viral myocarditis in mice
26. Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors
27. Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to β-adrenergic agonists
28. Isolation and expression of human cytokine synthesis inhibitory factor (CSIF/IL-10) cDNA clones: Homology to Epstein-Barr virus open reading frame BCRF1
29. Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis
30. Myocyte injury and contraction abnormalities produced by cytotoxic T lymphocytes
31. Therapeutic effect of anti-tumor necrosis factor-α antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus